Citation Impact
Citing Papers
Cell entry mechanisms of SARS-CoV-2
2020 Standout
Characterization of a canine homolog of hepatitis C virus
2011 StandoutNobel
Evidence for a functional RNA element in the hepatitis C virus core gene
2007 StandoutNobel
Immunotherapy of chronic hepatitis C virus infection with antibodies against programmed cell death-1 (PD-1)
2013 StandoutNobel
Residual risk of transfusion in Ghana
2001
CRISPR/Cas9 cleavage of viral DNA efficiently suppresses hepatitis B virus
2015 StandoutNatureNobel
De novo design of modular and tunable protein biosensors
2021 StandoutNatureNobel
The Spring α-Helix Coordinates Multiple Modes of HCV (Hepatitis C Virus) NS3 Helicase Action
2016 StandoutNobel
Naturally occurring NS3 resistance-associated variants in hepatitis C virus genotype 1: Their relevance for developing countries
2016
Evolving epidemiology of hepatitis C virus
2010
Mother–To–Infant Transmission of Hepatitis C Virus
2001
Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013
2015 Standout
Characteristics of hepatocellular carcinoma in Italy
1998
Mucoactive therapy in COPD
2010
Loss of viral fitness and cross-recognition by CD8+ T cells limit HCV escape from a protective HLA-B27–restricted human immune response
2009
Enhanced B-cell differentiation and reduced proliferative capacity in chronic hepatitis C and chronic hepatitis B virus infections
2010
euHCVdb: the European hepatitis C virus database
2006 StandoutNobel
Unravelling hepatitis C virus replication from genome to function
2005 StandoutNatureNobel
Randomised trial of interferon α2b plus ribavirin for 48 weeks or for 24 weeks versus interferon α2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus
1998 Standout
The Outcome of Hepatitis C Virus Infection Is Predicted by Escape Mutations in Epitopes Targeted by Cytotoxic T Lymphocytes
2001 StandoutNobel
Hepatitis B Virus Infection
2008
Hepatitis C virus genotype 1b as a risk factor for hepatocellular carcinoma development: A meta-analysis
2009
Nonprimate Hepaciviruses in Domestic Horses, United Kingdom
2012
Hepatocellular carcinoma
2012 Standout
Epidemiological and clinical burden of chronic hepatitis B virus/hepatitis C virus infection. A multicenter Italian study
2003
Diagnosis, management, and treatment of hepatitis C: An update # † ‡
2008 Standout
The changing epidemiology of hepatitis C virus infection in Europe
2007
Trends in mortality from hepatocellular carcinoma in Europe, 1980‐2004†
2008
Global epidemiology of hepatitis C virus infection
2005 Standout
Management of Hepatocellular Carcinoma *
2005 Standout
Prospects for a vaccine against the hepatitis C virus
2005 StandoutNatureNobel
Global cancer statistics
2011 Standout
Expression and detection of anti-HBs antibodies after hepatitis B virus infection or vaccination in the context of protective immunity
2019
A Human Monoclonal Antibody Targeting Scavenger Receptor Class B Type I Precludes Hepatitis C Virus Infection and Viral Spread In Vitro and In Vivo
2011 StandoutNobel
Cell culture–produced hepatitis C virus does not infect peripheral blood mononuclear cells
2008 StandoutNobel
Adaptive Immunity to the Hepatitis C Virus
2010
Expanded classification of hepatitis C virus into 7 genotypes and 67 subtypes: Updated criteria and genotype assignment web resource
2013 StandoutNobel
The Origin of Hepatitis C Virus
2013
The effect of interferon on the liver in chronic hepatitis C: a quantitative evaluation of histology by meta-analysis
1997
Oxidized low-density lipoprotein inhibits hepatitis C virus cell entry in human hepatoma cells
2006 StandoutNobel
Stable Cytotoxic T Cell Escape Mutation in Hepatitis C Virus Is Linked to Maintenance of Viral Fitness
2008 StandoutNobel
Nomenclature and Numbering of the Hepatitis C Virus
2009
Enhanced Activation of Memory, but Not Naïve, B Cells in Chronic Hepatitis C Virus-Infected Patients with Cryoglobulinemia and Advanced Liver Fibrosis
2013 StandoutNobel
Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance
2009 StandoutNature
Epidemiology of hepatitis C virus infection
2007
Mucolytic agents for chronic bronchitis or chronic obstructive pulmonary disease
2012
Characterization of host‐range and cell entry properties of the major genotypes and subtypes of hepatitis C virus†
2005
Global control of hepatitis C: where challenge meets opportunity
2013
Hepatitis C Virus Entry
2007 StandoutNobel
Airway Mucus Function and Dysfunction
2010 Standout
Hepatitis C virus genetic variability: pathogenic and clinical implications
2003
Understanding the hepatitis C virus life cycle paves the way for highly effective therapies
2013 StandoutNobel
The Global Spread of Hepatitis C Virus 1a and 1b: A Phylodynamic and Phylogeographic Analysis
2009
The NS5A Protein of Hepatitis C Virus Is a Zinc Metalloprotein
2004 StandoutNobel
A T-cell HCV vaccine eliciting effective immunity against heterologous virus challenge in chimpanzees
2006
The way forward in HCV treatment — finding the right path
2007 StandoutNobel
Hepatitis C virus kinetics and host responses associated with disease and outcome of infection in chimpanzees
2004 StandoutNobel
Visual Demonstration of Hepatitis C Virus–Specific Memory Cd8+ T–Cell Expansion in Patients With Acute Hepatitis C
2001
Hepatitis C virus sequences from different patients confirm the existence and transmissibility of subtype 2q, a rare subtype circulating in the metropolitan area of Barcelona, Spain
2011
Replication of hepatitis C virus
2007 StandoutNobel
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
2001 Standout
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
2012 Standout
Phylogenetic analyses confirm the high prevalence of hepatitis C virus (HCV) type 4 in the Seine-Saint-Denis district (France) and indicate seven different HCV-4 subtypes linked to two different epidemiological patterns
2001
Flying Under the Radar: The Immunobiology of Hepatitis C
2006 StandoutNobel
Genetic History of Hepatitis C Virus in East Asia
2008
Ultrastructural analysis of hepatitis C virus particles
2013 StandoutNobel
Characterization of nonprimate hepacivirus and construction of a functional molecular clone
2015 StandoutNobel
Claudin-6 and Claudin-9 Function as Additional Coreceptors for Hepatitis C Virus
2007
Human broadly neutralizing antibodies to the envelope glycoprotein complex of hepatitis C virus
2012 StandoutNobel
Diverse Hepatitis C Virus Glycoproteins Mediate Viral Infection in a CD81-Dependent Manner
2004 StandoutNobel
Heterologous T cell immunity in severe hepatitis C virus infection
2005
Antiapoptotic and Oncogenic Potentials of Hepatitis C Virus Are Linked to Interferon Resistance by Viral Repression of the PKR Protein Kinase
1999
High-Avidity Monoclonal Antibodies against the Human Scavenger Class B Type I Receptor Efficiently Block Hepatitis C Virus Infection in the Presence of High-Density Lipoprotein
2007 StandoutNobel
The Strange, Expanding World of Animal Hepaciviruses
2016
Studying Hepatitis C Virus: Making the Best of a Bad Virus
2007 StandoutNobel
Full-length sequences of 11 hepatitis C virus genotype 2 isolates representing five subtypes and six unclassified lineages with unique geographical distributions and genetic variation patterns
2012
Genetic diversity and evolution of hepatitis C virus – 15 years on
2004
Evolution of hepatitis C virus variants following blood transfusion from one infected donor to several recipients: a long-term follow-up
2004
Private aspects of heterologous immunity
2005
Viral persistence, liver disease, and host response in a hepatitis C–like virus rat model
2017 StandoutNobel
A Dynamic View of Hepatitis C Virus Replication Complexes
2008 StandoutNobel
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
2018 Standout
Time- and Temperature-Dependent Activation of Hepatitis C Virus for Low-pH-Triggered Entry
2006 StandoutNobel
Diverse CD81 Proteins Support Hepatitis C Virus Infection
2006 StandoutNobel
Turmeric curcumin inhibits entry of all hepatitis C virus genotypes into human liver cells
2013 StandoutNobel
Internal Disequilibria and Phenotypic Diversification during Replication of Hepatitis C Virus in a Noncoevolving Cellular Environment
2017 StandoutNobel
Hypervariable Region 1 Differentially Impacts Viability of Hepatitis C Virus Strains of Genotypes 1 to 6 and Impairs Virus Neutralization
2010
Role of Scavenger Receptor Class B Type I in Hepatitis C Virus Entry: Kinetics and Molecular Determinants
2009 StandoutNobel
Works of Enea Spada being referenced
Recombinant interferon-alpha and ursodeoxycholic acid versus interferon-alpha alone in the treatment of chronic hepatitis C: a randomized clinical trial with long-term follow-up.
1995
Case fatality rate of acute viral hepatitis in Italy: 1995–2000. An update
2003
High dosage alpha-interferon for treatment of children and young adults with chronic hepatitis C disease
1997
Naturally occurring mutations associated with resistance to HCV NS5B polymerase and NS3 protease inhibitors in treatment-naïve patients with chronic hepatitis C
2015
Molecular evolution of HCV genotype 2c persistent infection following mother-to-infant transmission
2000
Molecular heterogeneity and new subtypes of HCV genotype 4
1998
Estimating the incidence, prevalence and clinical burden of hepatitis C over time in Italy
2009
Acute Hepatitis B 14 Years after the Implementation of Universal Vaccination in Italy: Areas of Improvement and Emerging Challenges
2008
Correlation between virus genotype and chronicity rate in acute hepatitis C
1998
Changing epidemiology of parenterally transmitted viral hepatitis: results from the hepatitis surveillance system in Italy
2001
Changing Epidemiology of Hepatitis B in Italy: Public Health Implications
1992
Heterogeneity of Hepatitis C Virus Genotype 2 Variants in West Central Africa (Guinea Conakry)
1996
Multispecific T cell response and negative HCV RNA tests during acute HCV infection are early prognostic factors of spontaneous clearance
2004
Genotyping HCV isolates from Italy by type-specific PCR assay in the core region
1998
Impact of viral selected mutations on T cell mediated immunity in chronically evolving and self limiting acute HCV infection
2009
Hepatitis B immunity in teenagers vaccinated as infants: an Italian 17-year follow-up study
2014
Risk of parenterally transmitted hepatitis following exposure to surgery or other invasive procedures: results from the hepatitis surveillance system in Italy
2001
[Drugs active on mucus in the primary treatment of chronic bronchitis. Controlled study of the activity of letosteine].
1986
High prevalence of hepatitis B virus infection in B-cell non-Hodgkin's lymphoma.
2006
Positive selection of cytotoxic T lymphocyte escape variants during acute hepatitis C virus infection
2005